Balchem Corporation (NASDAQ:BCPC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 – Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers

Paul D. Coombs

24,047,866

3,001,276

Daniel E. Knutson

26,757,437

291,705

(ii)Ratification of the appointment of RSM LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2018: 29,708,891 shares in favor; 245,339 shares against; 23,734 shares abstaining.

(iii)Advisory vote to approve the Company’s executive compensation: 25,643,076 shares in favor; 1,264,629 shares against; 141,437 shares abstaining; and 2,928,822 broker non-votes.

About Balchem Corporation (NASDAQ:BCPC)

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. Its SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies-based nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. Its Industrial Products segment provides Choline Chloride and methylamines. The Company sells its products through its own sales force, independent distributors and sales agents.